July 1, 2025 · Form 4 insider transaction
LIGAND PHARMACEUTICALS INC bought 1,500,000 shares of PTHS at $10.00 per share, a transaction worth $15.00M. The trade was recorded as conversion of a derivative and disclosed on an SEC Form 4, filed 2 days after the transaction.
The numbers reported herein have been adjusted to reflect the 1-for-10 reverse stock split effected by the Issuer on July 1, 2025.